BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9771444)

  • 1. Reproducibility of new classification schemes for the pathology of ductal carcinoma in situ of the breast.
    Bethwaite P; Smith N; Delahunt B; Kenwright D
    J Clin Pathol; 1998 Jun; 51(6):450-4. PubMed ID: 9771444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology.
    Sloane JP; Amendoeira I; Apostolikas N; Bellocq JP; Bianchi S; Boecker W; Bussolati G; Coleman D; Connolly CE; Dervan P; Eusebi V; De Miguel C; Drijkoningen M; Elston CW; Faverley D; Gad A; Jacquemier J; Lacerda M; Martinez-Penuela J; Munt C; Peterse JL; Rank F; Sylvan M; Tsakraklides V; Zafrani B
    Hum Pathol; 1998 Oct; 29(10):1056-62. PubMed ID: 9781641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologists' agreement with experts and reproducibility of breast ductal carcinoma-in-situ classification schemes.
    Wells WA; Carney PA; Eliassen MS; Grove MR; Tosteson AN
    Am J Surg Pathol; 2000 May; 24(5):651-9. PubMed ID: 10800983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ductal carcinoma in situ of the breast: reproducibility of histological subtype analysis.
    Scott MA; Lagios MD; Axelsson K; Rogers LW; Anderson TJ; Page DL
    Hum Pathol; 1997 Aug; 28(8):967-73. PubMed ID: 9269834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma.
    Douglas-Jones AG; Gupta SK; Attanoos RL; Morgan JM; Mansel RE
    Histopathology; 1996 Nov; 29(5):397-409. PubMed ID: 8951484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consistency in the observation of features used to classify duct carcinoma in situ (DCIS) of the breast.
    Douglas-Jones AG; Morgan JM; Appleton MA; Attanoos RL; Caslin A; Champ CS; Cotter M; Dallimore NS; Dawson A; Fortt RW; Griffiths AP; Hughes M; Kitching PA; O'Brien C; Rashid AM; Stock D; Verghese A; Williams DW; Williams NW; Williams S
    J Clin Pathol; 2000 Aug; 53(8):596-602. PubMed ID: 11002762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic classification of breast ductal carcinoma-in-situ.
    Silverstein MJ; Poller DN; Waisman JR; Colburn WJ; Barth A; Gierson ED; Lewinsky B; Gamagami P; Slamon DJ
    Lancet; 1995 May; 345(8958):1154-7. PubMed ID: 7723550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility of three classification systems of ductal carcinoma in situ of the breast using a web-based survey.
    Schuh F; Biazús JV; Resetkova E; Benfica CZ; Edelweiss MI
    Pathol Res Pract; 2010 Oct; 206(10):705-11. PubMed ID: 20663616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytological and architectural heterogeneity in ductal carcinoma in situ of the breast.
    Quinn CM; Ostrowski JL
    J Clin Pathol; 1997 Jul; 50(7):596-9. PubMed ID: 9306942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical behavior of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ).
    Gupta SK; Douglas-Jones AG; Fenn N; Morgan JM; Mansel RE
    Cancer; 1997 Nov; 80(9):1740-5. PubMed ID: 9351542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cytomorphological and architectural heterogeneity in mammographically-detected ductal carcinoma in situ.
    Harrison M; Coyne JD; Gorey T; Dervan PA
    Histopathology; 1996 May; 28(5):445-50. PubMed ID: 8735720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of ductal carcinoma in-situ of breast and its correlation with the grade of associated invasive component.
    Konar K; Chatterjee U; Dutta SK
    Indian J Pathol Microbiol; 2001 Jul; 44(3):297-300. PubMed ID: 12024916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of necrosis and hypoxia in ductal carcinoma in situ of the breast: basis for a new classification.
    Bussolati G; Bongiovanni M; Cassoni P; Sapino A
    Virchows Arch; 2000 Oct; 437(4):360-4. PubMed ID: 11097360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ductal hyperplasia and ductal carcinoma in situ. Definition--classification--differential diagnosis].
    Böcker W; Decker T; Ruhnke M; Schneider W
    Pathologe; 1997 Jan; 18(1):3-18. PubMed ID: 9157402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
    Poller DN; Silverstein MJ; Galea M; Locker AP; Elston CW; Blamey RW; Ellis IO
    Mod Pathol; 1994 Feb; 7(2):257-62. PubMed ID: 7911998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological grading of breast ductal carcinoma in situ: validation of a web-based survey through intra-observer reproducibility analysis.
    Schuh F; Biazús JV; Resetkova E; Benfica CZ; Ventura Ade F; Uchoa D; Graudenz M; Edelweiss MI
    Diagn Pathol; 2015 Jul; 10():93. PubMed ID: 26159429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological controversies in breast cancer: classification of ductal carcinoma in situ, sentinel lymph nodes and low volume metastatic disease and reporting of neoadjuvant chemotherapy specimens.
    Provenzano E; Brown JP; Pinder SE
    Clin Oncol (R Coll Radiol); 2013 Feb; 25(2):80-92. PubMed ID: 23199579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear grade and comedo necrosis of ductal carcinoma in situ as histopathological eligible criteria for the Japan Clinical Oncology Group 1505 trial: an interobserver agreement study.
    Tsuda H; Yoshida M; Akiyama F; Ohi Y; Kinowaki K; Kumaki N; Kondo Y; Saito A; Sasaki E; Nishimura R; Fujii S; Homma K; Horii R; Murata Y; Itami M; Kajita S; Kato H; Kurosumi M; Sakatani T; Shimizu S; Taniguchi K; Tamiya S; Nakamura H; Kanbayashi C; Shien T; Iwata H
    Jpn J Clin Oncol; 2021 Mar; 51(3):434-443. PubMed ID: 33420502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening Pathology.
    Elston CW; Sloane JP; Amendoeira I; Apostolikas N; Bellocq JP; Bianchi S; Boecker W; Bussolati G; Coleman D; Connolly CE; Dervan P; Drijkoningen M; Eusebi V; Faverly D; Holland R; Jacquemier J; Lacerda M; Martinez-Penuela J; de Miguel C; Mossi S; Munt C; Peterse JL; Rank F; Reiner A; Sylvan M; Wells CA; Zafrani B
    Eur J Cancer; 2000 Sep; 36(14):1769-72. PubMed ID: 10974624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proposal for the histopathological diagnosis of ductal carcinoma in situ of the breast.
    Moriya T; Kasami M; Akiyama F; Ichihara S; Kurosumi M; Tsuda H; Umemura S; Akashi-Tanaka S; Imamura H; Iwase H; Shin E; Harada Y; Mitsuyama S; Ohuchi N
    Breast Cancer; 2000; 7(4):321-5. PubMed ID: 11114858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.